185
Views
9
CrossRef citations to date
0
Altmetric
Lens/Glaucoma

Association of NT-proANP Level in Plasma and Humor Aqueous with Primary Open-Angle Glaucoma

, &
Pages 233-236 | Received 12 Aug 2015, Accepted 13 Apr 2016, Published online: 10 Oct 2016

References

  • Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA 2014;311(18):1901–1911.
  • Doucette LP, Rasnitsyn A, Seifi M, Walter MA. The interactions of genes, age, and environment in glaucoma pathogenesis. Surv Ophthalmol 2015. pii: S0039-6257(15)00024-7.
  • Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120:1268–1279.
  • Quigley HA. Glaucoma. Lancet 2011;377:1367–1377.
  • Cherecheanu AP, Garhofer G, Schmidl D, Werkmeister R, Schmetterer L. Ocular perfusion pressure and ocular blood flow in glaucoma. Curr Opin Pharmacol 2013;13:36–42.
  • Deokule S, Weinreb RN. Relationships among systemic blood pressure, intraocular pressure, and open-angle glaucoma. Can J Ophthalmol 2008;43(3):302–307.
  • Leske MC, Warheit-Roberts L, Wu SY. Open-angle glaucoma and ocular hypertension: the Long Island Glaucoma Case-control Study. Ophthalmic Epidemiol 1996;3(2):85–96.
  • Leske MC, Wu SY, Hennis A, Honkanen R, Nemesure B. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmol 2008;115:85–93.
  • Memarzadeh F, Ying-Lai M, Chung J, Azen SP, Varma R. Blood pressure, perfusion pressure, and open-angle glaucoma: the Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci 2010;51:2872–2877.
  • Mitchell P, Lee AJ, Rochtchina E, Wang JJ. Open-angle glaucoma and systemic hypertension: the Blue Mountains Eye Study. J Glaucoma 2004;13(4):319–326.
  • Abegão Pinto L, Willekens K, Van Keer K, Shibesh A, Molenberghs G, Vandewalle E, Stalmans I. Ocular blood flow in glaucoma—the Leuven Eye Study. Acta Ophthalmol 2016. doi: 10.1111/aos.12962.
  • Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 2006;27(1):47–72.
  • Bianchi C, Anand-Srivastava MB, De Lean A, Gutkowska J, Forthomme D, Genest J, Cantin M. Localization and characterization of specific receptors for atrial natriuretic factor in the ciliary processes of the eye. Curr Eye Res 1986;5:283–293.
  • Mittag TW, Tormay A, Ortega M, Severin C. Atrial natriuretic peptide (ANP), guanylate cyclase, and intraocular pressure in the rabbit eye. Curr Eye Res 1987;6:1189–1196.
  • Nathanson JA. Atriopeptin-activated guanylate cyclase in the anterior segment. Identification, localization, and effects of atriopeptins on IOP. Invest Ophthalmol Vis Sci 1987;28:1357–1364.
  • Sugrue MF, Viader MP. Synthetic atrial natriuretic factor lowers rabbit intraocular pressure. Eur J Pharmacol 1986;130(3):349–350.
  • Korenfeld MS, Becker B. Atrial natriuretic peptides. Effects on intraocular pressure, cGMP, and aqueous flow. Invest Ophthalmol Vis Sci 1989;30(11):2385–2392.
  • Takashima Y, Taniguchi T, Yoshida M, Haque MS, Yoshimura N, Honda Y. Ocular hypotensive mechanism of intravitreally injected brain natriuretic peptide in rabbit. Invest Ophthalmol Vis Sci 1996;37(13):2671–2677.
  • Diestelhorst M, Krieglstein GK. The intraocular pressure response of human atrial natriuretic factor in glaucoma. Int Ophthalmol 1989;13(1–2):99–101.
  • Goldmann DB, Waubke N. A pilot study on the effect of atrial natriuretic peptide on intraocular pressure in the human. Fortschr Ophthalmol 1989;86(5):494–496.
  • Salzmann J, Flitcroft D, Bunce C, Gordon D, Wormald R, Migdal C. Brain natriuretic peptide: identification of a second natriuretic peptide in human aqueous humour. Br J Ophthalmol 1998;82(7):830–834.
  • Fernandez-Durango R, Nunez DJ, Brown MJ. Messenger RNAs encoding the natriuretic peptides and their receptors are expressed in the eye. Exp Eye Res 1995;61(6):723–729.
  • Rollín R, Mediero A, Roldán-Pallarés M, Fernández-Cruz A, Fernández-Durango R. Natriuretic peptide system in the human retina. Mol Vis 2004;10:15–22.
  • Cammarata PR, Braun B, Dimitrijevich SD, Pack J. Characterization and functional expression of the natriuretic peptide system in human lens epithelial cells. Mol Vis 2010;16:630–638.
  • Katoli P, Sharif NA, Sule A, Dimitrijevich SD. NPR-B natriuretic peptide receptors in human corneal epithelium: mRNA, immunohistochemistochemical, protein, and biochemical pharmacology studies. Mol Vis 2010;16:1241–1252.
  • Buys ES, Potter LR, Pasquale LR, Ksander BR. Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma. Front Mol Neurosci 2014;7:38.
  • Mills RP, Budenz DL, Lee PP, Noecker RJ, Walt JG, Siegartel LR, Evans SJ, Doyle JJ. Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol 2006;141:24–30.
  • Flammer J, Konieczka K, Bruno RM, Virdis A, Flammer AJ, Taddei S. The eye and the heart. Eur Heart J 2013;34(17):1270–1278.
  • Sato C, Kaneko H, Kondo T, Takayama K, Yasuda S, Terasaki H. Association of intraocular pressure changes with right ventricular diameter and brain natriuretic peptide in a case of pulmonary arterial hypertension. J Glaucoma 2016;25(3):e295–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.